Tilray Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.9
- Today's High:
- $3.28
- Open Price:
- $3.22
- 52W Low:
- $1.5
- 52W High:
- $5.12
- Prev. Close:
- $3.31
- Volume:
- 59766363
Company Statistics
- Market Cap.:
- $2.10 billion
- Book Value:
- 5.049
- Revenue TTM:
- $627.12 million
- Operating Margin TTM:
- -28.73%
- Gross Profit TTM:
- $116.82 million
- Profit Margin:
- -231.64%
- Return on Assets TTM:
- -2.31%
- Return on Equity TTM:
- -37.14%
Company Profile
Tilray Inc had its IPO on 2018-07-19 under the ticker symbol TLRY.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Tilray Inc has a staff strength of 1,600 employees.
Stock update
Shares of Tilray Inc opened at $3.22 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.9 - $3.28, and closed at $2.91.
This is a -12.08% slip from the previous day's closing price.
A total volume of 59,766,363 shares were traded at the close of the day’s session.
In the last one week, shares of Tilray Inc have slipped by -2.68%.
Tilray Inc's Key Ratios
Tilray Inc has a market cap of $2.10 billion, indicating a price to book ratio of 0.458 and a price to sales ratio of 3.2087.
In the last 12-months Tilray Inc’s revenue was $627.12 million with a gross profit of $116.82 million and an EBITDA of $-50016000. The EBITDA ratio measures Tilray Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Tilray Inc’s operating margin was -28.73% while its return on assets stood at -2.31% with a return of equity of -37.14%.
In Q2, Tilray Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 20.1%.
Tilray Inc’s PE and PEG Ratio
- Forward PE
- 1000
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-2.9 per share while it has a forward price to earnings multiple of 1000 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tilray Inc’s profitability.
Tilray Inc stock is trading at a EV to sales ratio of 3.6505 and a EV to EBITDA ratio of -7.8271. Its price to sales ratio in the trailing 12-months stood at 3.2087.
Tilray Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $4.31 billion
- Total Liabilities
- $432.98 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $12.41 million
- Dividend Payout Ratio
- 0%
Tilray Inc ended 2024 with $4.31 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $4.31 billion while shareholder equity stood at $3.32 billion.
Tilray Inc ended 2024 with $0 in deferred long-term liabilities, $432.98 million in other current liabilities, 66000.00 in common stock, $-2415507000.00 in retained earnings and $2.01 billion in goodwill. Its cash balance stood at $206.63 million and cash and short-term investments were $448.53 million. The company’s total short-term debt was $224,262,000 while long-term debt stood at $0.
Tilray Inc’s total current assets stands at $773.03 million while long-term investments were $0 and short-term investments were $241.90 million. Its net receivables were $86.23 million compared to accounts payable of $70.82 million and inventory worth $200.55 million.
In 2024, Tilray Inc's operating cash flow was $0 while its capital expenditure stood at $12.41 million.
Comparatively, Tilray Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $2.91
- 52-Week High
- $5.12
- 52-Week Low
- $1.5
- Analyst Target Price
- $2.64
Tilray Inc stock is currently trading at $2.91 per share. It touched a 52-week high of $5.12 and a 52-week low of $5.12. Analysts tracking the stock have a 12-month average target price of $2.64.
Its 50-day moving average was $2.31 and 200-day moving average was $2.57 The short ratio stood at 2.88 indicating a short percent outstanding of 0%.
Around 139.6% of the company’s stock are held by insiders while 1003.1% are held by institutions.
Frequently Asked Questions About Tilray Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.